MEP Francoise Grossetête: EU PMA may not be necessary, but patient safety must be considered at all costs
This article was originally published in Clinica
Executive Summary
The roundtable organised last week by French medtech industry association Snitem on the medical device directives revision was a micro version of the larger debate that is going on in Europe. Amanda Maxwell reports from Paris
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.